Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology

被引:4
|
作者
Qiang, Rui [1 ]
Zhang, Ya [1 ,2 ]
Wang, Yanhong [3 ,4 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing 100053, Peoples R China
[2] Shaanxi Univ Chinese Med, Xianyang 712046, Peoples R China
[3] Tongji Univ, Tongji Hosp, Sch Med, Dept Orthoped, Shanghai 200065, Peoples R China
[4] Minist Educ, Key Lab Spine & Spinal Cord Injury Repair & Regene, Shanghai 200065, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN; 90; INHIBITOR; LIVER FIBROSIS; BETA-SITOSTEROL; STELLATE CELLS; QUERCETIN; PREDICTION; INJURY; INFLAMMATION; PROGRESSION; DOCKING;
D O I
10.1155/2022/8925637
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose. To explore the material basis and pharmacological mechanism of Xiaochaihu Decoction (XCHD), the classic Traditional Chinese Medicine (TCM) formula in inhibiting hepatic fibrosis (HF). Methods. The main components in XCHD were screened from the TCMSP database, ETCM database, and literature, and their potential targets were detected and predicted using the Swiss Target Prediction platform. The HF-related targets were retrieved and screened through GeneCard database and OMIM database, combined with GEO gene chips. The XCHD targets and HF targets were mapped to search common targets. The protein-protein interaction (PPI) network was acquired via the STRING11.0 database and analyzed visually using Cytoscape 3.8.0 software. The potential mechanisms of the common targets identified through GO and KEGG pathway enrichment analysis were analyzed by using Metascape database. The results were visualized through OmicShare Tools. The "XCHD compound-HF target" network was visually constructed by Cytoscape 3.8.0 software. AutoDockVina1.1.2 and PyMoL software were used to verify the molecular docking of XCHD main active compounds and HF key targets. Results. A total of 164 potential active compounds from XCHD were screened to act on 95 HF-related targets. Bioinformatics analysis revealed that quercetin, beta-sitosterol, and kaempferol may be candidate agents, which acted on multiple targets like PTGS2, HSP90AA1, and PTGS1 and regulate multiple key biological pathways like IL-17 signaling pathway, TNF signaling pathway and PI3K-Akt signaling pathway to relieve HF. Moreover, molecular docking suggested that quercetin and PTGS2 could statically bind and interact with each other through amino acid residues val-349, LEU-352, PHE-381, etc. Conclusion. This work provides a systems perspective to study the relationship between Chinese medicines and diseases. The therapeutic efficacy of XCHD on HF was the sum of multitarget and multi-approach effects from the bioactive ingredients. This study could be one of the cornerstones for further research.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction
    Guo, Jun-feng
    Zhao, Yu-ting
    Du, Quan-yu
    Ren, Yuan
    Wang, Yan
    Wang, Zhen-xing
    Jin, Wei
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [42] Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
    Gong, Zhaohui
    Li, Rong
    Chen, Shulin
    Wu, Hui
    Cai, Yinhe
    Li, Junlong
    Zhao, Xinjun
    Chu, Qingmin
    Luo, Chuanjin
    Qing, Lijin
    Li, Nan
    Wu, Wei
    Journal of Healthcare Engineering, 2022, 2022
  • [43] A Network Pharmacology-Based Study of the Molecular Mechanisms of Shaoyao-Gancao Decoction in Treating Parkinson's Disease
    Li, Liting
    Qiu, Haiyan
    Liu, Mimi
    Cai, Yongming
    INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2020, 12 (02) : 131 - 144
  • [44] Utilizing network pharmacology to explore the underlying mechanism of wenshenxuanbi decoction in treating osteoarthritis
    Xia, Tianwei
    Huang, Dawei
    Mao, Guoqing
    Liu, Jinzhu
    Shi, Jiayong
    Yuan, Zhaofeng
    Shen, Jirong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (10): : 7427 - 7436
  • [45] A Network Pharmacology-Based Study of the Molecular Mechanisms of Shaoyao-Gancao Decoction in Treating Parkinson’s Disease
    Liting Li
    Haiyan Qiu
    Mimi Liu
    Yongming Cai
    Interdisciplinary Sciences: Computational Life Sciences, 2020, 12 : 131 - 144
  • [46] A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage
    Cheng, Menghan
    Li, Teng
    Hu, En
    Yan, Qiuju
    Li, Haigang
    Wang, Yang
    Luo, Jiekun
    Tang, Tao
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
  • [47] Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
    Gong, Zhaohui
    Li, Rong
    Chen, Shulin
    Wu, Hui
    Cai, Yinhe
    Li, Junlong
    Zhao, Xinjun
    Chu, Qingmin
    Luo, Chuanjin
    Qing, Lijin
    Li, Nan
    Wu, Wei
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [48] Potential therapeutic targets and biological mechanisms of Centella asiatica on hepatic fibrosis: a study of network pharmacology
    Fan, Yuli
    Yin, Xiaoyan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (11)
  • [49] Investigating Xiaochaihu Decoction's fever-relieving mechanism via network pharmacology, molecular docking, dynamics simulation, and experiments
    Lei, Hong
    Su, Hongbing
    Cao, Ling
    Zhou, Xiaoying
    Liu, Yumeng
    Li, Ying
    Song, Xiaoxue
    Wang, Yanhong
    Guan, Qingxia
    ANALYTICAL BIOCHEMISTRY, 2024, 694
  • [50] The Mechanisms of Sijunzi Decoction in the Treatment of Chronic Gastritis Revealed by Network Pharmacology
    Wang, Ting
    Feng, Yuyin
    Wang, Hesong
    Huo, Guiyang
    Cai, Yanan
    Wang, Li
    Yuan, Kai
    Huang, Guangrui
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020